Single-center retrospective review of ultrasound-accelerated versus traditional catheter-directed thrombolysis for acute lower extremity deep venous thrombosis

Abstract

Objective

Systemic anticoagulation remains the standard for acute lower extremity (LE) deep venous thrombosis (DVT), but growing interest in catheter-directed thrombolysis (CDT) and its potential to reduce the incidence of post-thrombotic syndrome (PTS) has led to advent of ultrasound-accelerated CDT (US-CDT). Few studies to date have examined the outcomes of US-CDT against traditional CDT (T-CDT).

Methods

This is a retrospective, single-center review of all patients treated for acute LE DVT over a five-year period with either US- and T-CDT. Patients were stratified based on demographics, presentation, co-morbidities, risk factors, and peri-procedural data.

Results

Seventy-six limbs in 67 patients were treated; 51 limbs in 42 patients were treated with US-CDT, and 25 limbs in 25 patients were treated with T-CDT. Adjuncts include: pharmacomechanical thrombolysis (n = 28 vs. 20, p = 0.04), angioplasty (n = 22 vs. 18, p = 0.11), stenting (n = 30 vs. 6, p ≤ 0.001), and IVC filter insertion (n = 5 vs. 0, p = 0.07). Mean lysis times were 21 ± 1.7 and 24 ± 1.8 h for US- and T-CDT, respectively (p = 0.26). Thirty (25 ultrasound, 5 traditional) limbs had complete lysis. Thirty-one (22 ultrasound, 9 traditional) limbs had incomplete lysis. Fifteen (4 ultrasound, 11 traditional) limbs had ineffective lysis (p = 0.002 in favor of ultrasound). Four patients (3 US-CDT, 1 T-CDT) had recurrent ipsilateral thrombosis within 30 days (p = 0.60). By Kaplan-Meier analysis, there were no significant difference between primary patency, primary-assisted patency, secondary patency, re-thrombosis, and recurrent symptoms at 6, 12, and 24 months.

Conclusion

US-CDT does not significantly improve mid-term patencies but results in greater acute clot burden reduction in patients with acute LE DVTs compared to T-CDT, which may be beneficial in reducing the long-term incidence of PTS.

Keywords

EKOS CDT thrombolysis ultrasound outcomes DVT

Get full access to this article

View all access options for this article.

References

ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Thromb Res 2014; 134: 931–938.

Prandoni

Villalta

Bagatella

et al.

The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997; 82: 423–428.

Comerota

Gravett

. Iliofemoral venous thrombosis. J Vasc Surg 2007; 46: 1065–1076.

Enden

Haig

Kløw

N-E

et al.

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012; 379: 31–38.

Davies

. Deep venous thrombosis: prevention and treatment. Methodist DeBakey Cardiovasc J 2009; 5: 25–31.

Braaten

Goss

Francis

. Ultrasound reversibly disaggregates fibrin fibers. Thromb Haemost 1997; 78: 1063–1068.

Francis

Blinc

Lee

et al.

Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 1995; 21: 419–424.

Grommes

Strijkers

Greiner

et al.

Safety and feasibility of ultrasound-accelerated catheter-directed thrombolysis in deep vein thrombosis. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg 2011; 41: 526–532.

Mewissen

Seabrook

Meissner

et al.

Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999; 211: 39–49.

10.

Parikh

Motarjeme

McNamara

et al.

Ultrasound-accelerated thrombolysis for the treatment of deep vein thrombosis: initial clinical experience. J Vasc Interv Radiol 2008; 19: 521–528.

11.

Kearon

Akl

Comerota

et al.

Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e419S–94S.

12.

Meissner

Gloviczki

Comerota

et al.

Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2012; 55: 1449–1462.

13.

Dumantepe

Tarhan

Ozler

. Treatment of chronic deep vein thrombosis using ultrasound accelerated catheter-directed thrombolysis. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg 2013; 46: 366–371.

14.

Schrijver

van Leersum

Fioole

et al.

Dutch randomized trial comparing standard catheter-directed thrombolysis and ultrasound-accelerated thrombolysis for arterial thromboembolic infrainguinal disease (DUET). J Endovasc Ther Off J Int Soc Endovasc Spec 2015; 22: 87–95.

15.

Kim

Patra

Paxton

et al.

Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes. J Vasc Interv Radiol 2006; 17: 1099–1104.

16.

Engelberger

Spirk

Willenberg

et al.

Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv 2015; 8: e002027–e002027.

17.

Baker

Samuels

Benenati

et al.

Ultrasound-accelerated vs standard catheter-directed thrombolysis – a comparative study in patients with iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2012; 23: 1460–1466.

18.

Protack

Bakken

Patel

et al.

Long-term outcomes of catheter directed thrombolysis for lower extremity deep venous thrombosis without prophylactic inferior vena cava filter placement. J Vasc Surg 2007; 45: 992–927; discussion 997.